Literature DB >> 25875957

Correction: CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.

Silvia Vogl, Roman W Lutz, Gilbert Schönfelder, Werner K Lutz.   

Abstract

Entities:  

Year:  2015        PMID: 25875957      PMCID: PMC4395445          DOI: 10.1371/journal.pone.0126329

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There is an error in the third sentence of the second paragraph of the “Subjects and treatment” subsection of the Methods. The correct sentence is: According to the study design, which also designated phenotyping for CYP2D6, 10 mg dextromethorphan in water (DEX, as dextromethorphan hydrobromide monohydrate, Fagron, Barsbüttel, Germany) had been administered simultaneously.
  1 in total

1.  CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.

Authors:  Silvia Vogl; Roman W Lutz; Gilbert Schönfelder; Werner K Lutz
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

  1 in total
  2 in total

1.  Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine.

Authors:  Weize Huang; Lindsay C Czuba; Nina Isoherranen
Journal:  J Pharmacol Exp Ther       Date:  2020-03-20       Impact factor: 4.030

Review 2.  The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review.

Authors:  Erika L Meaddough; Sara M Sarasua; Tracy K Fasolino; Christopher L Farrell
Journal:  Pharmacogenomics J       Date:  2021-06-17       Impact factor: 3.550

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.